🏥 Max Healthcare – India’s Apollo 2.0 or Just a ₹1.2 Lakh Cr Bed Charge?
1. 🧠 At a Glance
Max Healthcare is India’s second-largest hospital chain by revenue and EBITDA, with operations across Delhi-NCR, Mumbai, and North India. It’s growing fast, printing strong profits, and operating at ~27% margins. But with a PE of 105, and promoter holding down to 23.7%, the stock feels like it needs an ICU — for its valuation.
2. 🎬 Introduction with Hook
Imagine charging ₹5,000 for an MRI and still not being able to explain to the patient why the doctor hasn’t arrived. That’s healthcare in India.
But Max Healthcare figured out how to do it profitably — without being government-run or doctor-led. With its IPO, aggressive expansion, margin control, and EBITDA of ₹1,849 Cr in FY25, Max now sits pretty at a ₹1.18 lakh Cr market cap.
The problem? The stock is priced like it’s curing cancer every quarter.
3. 🏭 Business Model (WTF Do They Even Do?)
Max runs a hospital-centric business model:
🏥 17+ Hospitals
🧪 4,000+ operational beds
⚕️ Strong focus on oncology, cardiology, orthopaedics, transplants
💼 Mix of owned hospitals, leased assets, and operated centers
📈 ~80% of revenue comes from 4-5 flagship locations (Delhi NCR = cash cow)
Plus:
Max Lab diagnostics (vertical integration)
Day-care centres, pathology, and medical tourism (~12–14% of revenue)
Pan-India Expansion: Focused mostly on urban Tier-1
